View Cart (0 items)
Fabry disease drug moves to FDA fast track

Genzyme announced on Monday that the Food and Drug Administration has granted Fast Track designation for the development of GZ/SAR402671, a new investigational therapy for the treatment of Fabry disease

Amgen first quarter beats Wall Street expectations

Amgen reported first-quarter profit that beat Wall Street expectations, which the company attributed to an increase in demand, and price, for their drugs

DaVita to settle whistleblower suit over drug-billing fraud

DaVita HealthCare Partners is settling a whistleblower suit filed in Atlanta, ending a legal battle between DaVita's Kidney Care division and two former employees that began in 2007

SGR fix also expands role of advanced practice nurses

The legislation passed by the Senate April 14 that would permanently remove the sustainable growth rate formula, also allows nurse practitioners and clinical nurse specialists to document the face-to-face encounters with Medicare patients required to write prescriptions for durable medical equipment

WHAT'S NEW

Rss
Rss

Blogs

Meaningful Use Stage 3 proposed rule: A closer look at the objectives

Meaningful Use Stage 3 proposed rule: A closer look at the objectives

Some aspects of the Centers for Medicare & Medicaid Services' Meaningful Use Stage 3 proposed rule are good (such as simplifying the number of objectives), but some seem very ambitious.

More
A New Year for Dialysis—Home and In-Center

A New Year for Dialysis—Home and In-Center

Let 2015 be the year of nocturnal home HD, and the year that U.S. in-center dialysis outcomes catch up with the rest of the world

More

WHAT'S NEW

Rss
Rss

Blogs

Meaningful Use Stage 3 proposed rule: A closer look at the objectives

Meaningful Use Stage 3 proposed rule: A closer look at the objectives

Some aspects of the Centers for Medicare & Medicaid Services' Meaningful Use Stage 3 proposed rule are good (such as simplifying the number of objectives), but some seem very ambitious.

More
A New Year for Dialysis—Home and In-Center

A New Year for Dialysis—Home and In-Center

Let 2015 be the year of nocturnal home HD, and the year that U.S. in-center dialysis outcomes catch up with the rest of the world

More